ArticleAnnals of surgical oncology2026
Comparison of Short-Term Outcomes Between Robot-Assisted and Conventional Mediastinoscopic Esophagectomies: A Retrospective Study Using Propensity Score Matching.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Outcomes of transmediastinal esophagectomy for patients with esophagogastric junction cancers.International journal of clinical oncology · 2026Article
- Single-sterilization modified-position robotic-assisted McKeown esophagectomy versus minimally invasive approach after neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMediastinoscopic esophagectomy (ME) is a minimally invasive surgery for esophageal cancer that avoids one-lung ventilation and chest wall trauma. However, a major challenge with this technique is the relatively high incidence of left recurrent laryngeal nerve palsy (RLNP). To address this, we introduced a transcervical mediastinoscopic and transabdominal robot-assisted esophagectomy (RA-ME) technique. The clinical significance of robotic assistance in ME was evaluated by comparing RA-ME and conventional ME (Co-ME), using propensity score matching (PSM) to control for baseline characteristics.
methodsWe retrospectively reviewed patients who underwent ME for esophageal or esophagogastric junction cancer between April 2018 and March 2025. Patients were classified into RA-ME and Co-ME groups. PSM was performed using five covariates, resulting in 68 matched pairs (n = 136). The primary endpoint was the incidence of left RLNP, whereas secondary endpoints included operative time, blood loss, complications, lymph node yield, and R0 resection rate.
resultsA total of 136 matched patients (RA-ME, n = 68; Co-ME, n = 68) were analyzed after PSM. The RA-ME group had a significantly lower RLNP incidence (19.1% vs 38.2%, p = 0.022) and less intraoperative blood loss than the Co-ME group (99.8 ± 116.1 mL vs 251.0 ± 821.1 mL, p = 0.001). Operative time, complication rates, lymph node yield, and R0 resection rates were comparable between the groups.
conclusionsRA-ME significantly reduced RLNP incidence, nearly halving it, and lowered intraoperative blood loss without compromising oncologic quality. These findings support the potential use of RA-ME as a standard approach in select cases of minimally invasive esophageal cancer surgery.
Indexed as
Identifiers
41429961What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.